High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma

BACKGROUND: MLL2 has been identified as one of the most frequently mutated genes in a variety of cancers including esophageal squamous cell carcinoma (ESCC). However, its clinical significance and prognostic value in ESCC has not been elucidated. In the present study, we aimed to investigate the exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Abudureheman, Abulajiang, Ainiwaer, Julaiti, Hou, Zhichao, Niyaz, Madiniyat, Turghun, Abdugheni, Hasim, Ayshamgul, Zhang, Haiping, Lu, Xiaomei, Sheyhidin, Ilyar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948284/
https://www.ncbi.nlm.nih.gov/pubmed/29532228
http://dx.doi.org/10.1007/s00432-018-2625-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5948284/
https://www.ncbi.nlm.nih.gov/pubmed/29532228
http://dx.doi.org/10.1007/s00432-018-2625-5

Ejemplares similares